These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 36565756)

  • 21. SARS-CoV-2 nsp13 Restricts Episomal DNA Transcription without Affecting Chromosomal DNA.
    Li A; Zhang B; Zhao K; Yin Z; Teng Y; Zhang L; Xu Z; Liang K; Cheng X; Xia Y
    J Virol; 2023 Jul; 97(7):e0051223. PubMed ID: 37347173
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Review on
    Cetin Y; Aydinlik S; Gungor A; Kan T; Avsar T; Durdagi S
    Curr Med Chem; 2022; 29(38):5925-5948. PubMed ID: 35761502
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A robust high-throughput fluorescent polarization assay for the evaluation and screening of SARS-CoV-2 fusion inhibitors.
    Yin X; Chen L; Yuan S; Liu L; Gao Z
    Bioorg Chem; 2021 Nov; 116():105362. PubMed ID: 34598089
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Label-Free Screening of SARS-CoV-2 NSP14 Exonuclease Activity Using SAMDI Mass Spectrometry.
    Scholle MD; Liu C; Deval J; Gurard-Levin ZA
    SLAS Discov; 2021 Jul; 26(6):766-774. PubMed ID: 33870746
    [TBL] [Abstract][Full Text] [Related]  

  • 25. High-throughput assay using a GFP-expressing replicon for SARS-CoV drug discovery.
    Ge F; Xiong S; Lin FS; Zhang ZP; Zhang XE
    Antiviral Res; 2008 Nov; 80(2):107-13. PubMed ID: 18584889
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Development of a homogeneous screening assay for automated detection of antiviral agents active against severe acute respiratory syndrome-associated coronavirus.
    Ivens T; Van den Eynde C; Van Acker K; Nijs E; Dams G; Bettens E; Ohagen A; Pauwels R; Hertogs K
    J Virol Methods; 2005 Oct; 129(1):56-63. PubMed ID: 15961169
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Establishment of a stable SARS-CoV-2 replicon system for application in high-throughput screening.
    Tanaka T; Saito A; Suzuki T; Miyamoto Y; Takayama K; Okamoto T; Moriishi K
    Antiviral Res; 2022 Mar; 199():105268. PubMed ID: 35271914
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Generation of a SARS-CoV-2 Reverse Genetics System and Novel Human Lung Cell Lines That Exhibit High Virus-Induced Cytopathology.
    Khan JQ; Rohamare M; Rajamanickam K; Bhanumathy KK; Lew J; Kumar A; Falzarano D; Vizeacoumar FJ; Wilson JA
    Viruses; 2023 May; 15(6):. PubMed ID: 37376581
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Stable Cell Clones Harboring Self-Replicating SARS-CoV-2 RNAs for Drug Screen.
    Liu S; Chou CK; Wu WW; Luan B; Wang TT
    J Virol; 2022 Mar; 96(6):e0221621. PubMed ID: 35080424
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Development of a replicon cell line-based high throughput antiviral assay for screening inhibitors of Zika virus.
    Li JQ; Deng CL; Gu D; Li X; Shi L; He J; Zhang QY; Zhang B; Ye HQ
    Antiviral Res; 2018 Feb; 150():148-154. PubMed ID: 29288699
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A highly sensitive cell-based luciferase assay for high-throughput automated screening of SARS-CoV-2 nsp5/3CLpro inhibitors.
    Chen KY; Krischuns T; Varga LO; Harigua-Souiai E; Paisant S; Zettor A; Chiaravalli J; Delpal A; Courtney D; O'Brien A; Baker SC; Decroly E; Isel C; Agou F; Jacob Y; Blondel A; Naffakh N
    Antiviral Res; 2022 May; 201():105272. PubMed ID: 35278581
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Generation and Characterization of recombinant SARS-CoV-2 expressing reporter genes.
    Chiem K; Morales Vasquez D; Park JG; Platt RN; Anderson T; Walter MR; Kobie JJ; Ye C; Martinez-Sobrido L
    J Virol; 2021 Mar; 95(7):. PubMed ID: 33431557
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Biological activity-based modeling identifies antiviral leads against SARS-CoV-2.
    Huang R; Xu M; Zhu H; Chen CZ; Zhu W; Lee EM; He S; Zhang L; Zhao J; Shamim K; Bougie D; Huang W; Xia M; Hall MD; Lo D; Simeonov A; Austin CP; Qiu X; Tang H; Zheng W
    Nat Biotechnol; 2021 Jun; 39(6):747-753. PubMed ID: 33623157
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antiviral Activity of Type I, II, and III Interferons Counterbalances ACE2 Inducibility and Restricts SARS-CoV-2.
    Busnadiego I; Fernbach S; Pohl MO; Karakus U; Huber M; Trkola A; Stertz S; Hale BG
    mBio; 2020 Sep; 11(5):. PubMed ID: 32913009
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identifying Small-Molecule Inhibitors of SARS-CoV-2 RNA-Dependent RNA Polymerase by Establishing a Fluorometric Assay.
    Bai X; Sun H; Wu S; Li Y; Wang L; Hong B
    Front Immunol; 2022; 13():844749. PubMed ID: 35464436
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification of a broad-spectrum antiviral small molecule against severe acute respiratory syndrome coronavirus and Ebola, Hendra, and Nipah viruses by using a novel high-throughput screening assay.
    Elshabrawy HA; Fan J; Haddad CS; Ratia K; Broder CC; Caffrey M; Prabhakar BS
    J Virol; 2014 Apr; 88(8):4353-65. PubMed ID: 24501399
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Construction and characterization of two SARS-CoV-2 minigenome replicon systems.
    Zhang H; Fischer DK; Shuda M; Moore PS; Gao SJ; Ambrose Z; Guo H
    J Med Virol; 2022 Jun; 94(6):2438-2452. PubMed ID: 35137972
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A Simplified Quantitative Real-Time PCR Assay for Monitoring SARS-CoV-2 Growth in Cell Culture.
    Shema Mugisha C; Vuong HR; Puray-Chavez M; Bailey AL; Fox JM; Chen RE; Wessel AW; Scott JM; Harastani HH; Boon ACM; Shin H; Kutluay SB
    mSphere; 2020 Sep; 5(5):. PubMed ID: 32878932
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A recombinant Cedar virus based high-throughput screening assay for henipavirus antiviral discovery.
    Amaya M; Cheng H; Borisevich V; Navaratnarajah CK; Cattaneo R; Cooper L; Moore TW; Gaisina IN; Geisbert TW; Rong L; Broder CC
    Antiviral Res; 2021 Sep; 193():105084. PubMed ID: 34077807
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Development and characterization of a stable luciferase dengue virus for high-throughput screening.
    Zou G; Xu HY; Qing M; Wang QY; Shi PY
    Antiviral Res; 2011 Jul; 91(1):11-9. PubMed ID: 21575658
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.